Arkansas SB331: CONCERNING COVERAGE FOR GENETIC TESTING FOR INHERITED CANCER MUTATIONS; AND TO CREATE THE GENETIC TESTING ACT

What the bill says

An act to be entitled an act concerning coverage for genetic testing for inherited cancer mutations; to create the genetic testing act; and for other purposes. subtitle concerning coverage for genetic testing for inherited cancer mutations; and to create the genetic testing act.

From the introduced text:

An Act To Be Entitled AN ACT CONCERNING COVERAGE FOR GENETIC TESTING FOR INHERITED CANCER MUTATIONS; TO CREATE THE GENETIC TESTING ACT; AND FOR OTHER PURPOSES. Subtitle CONCERNING COVERAGE FOR GENETIC TESTING FOR INHERITED CANCER MUTATIONS; AND TO CREATE THE GENETIC TESTING ACT. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS: SECTION 1. Arkansas Code Title 23, Chapter 79, is amended to add an additional subchapter to read as follows: Subchapter 29 -- Genetic Testing Act 23-79-2901. Title. This subchapter shall be known and may be cited as the "Genetic Testing Act". 23-79-2902. Definitions. As used in this subchapter: (1) "Clinical genetic testing for an inherited cancer mutation" means germline testing for an inherited mutation associated with an increased cancer risk according to evidence-based, clinical practice guidelines; (2) "Cost-sharing requirements" means a deductible payment, coinsurance amount, copayment, or any similar out-of-pocket expense; *ANS185* 03-20-2025 15:42:50 ANS185 As Engrossed: S3/20/25 SB331 (3) "Enrollee" means an individual entitled to coverage of healthcare services from a healthcare insurer; (4) "Evidence-based cancer imaging" means an evidence-based cancer imaging modalities according to the National Comprehensive Cancer Network clinical practice guidelines; (5)(A) "Health benefit plan" means any individual, blanket, or group plan, policy, or contract for healthcare services issued or delivered by a healthcare insurer in this state. (B) "Health benefit plan" …

Read the full official text

Sponsors

• Greg Leding (D, 30) · primary sponsor
• Lee Johnson (R, 47)

Latest actions

1. May 5, 2025: Died in House Committee at Sine Die adjournment.
2. March 31, 2025: Read the first time, rules suspended, read the second time and referred to the Committee on INSURANCE & COMMERCE- HOUSE
3. March 31, 2025: RECEIVED FROM THE SENATE
4. March 31, 2025: Ordered immediately transmitted to the House.
5. March 31, 2025: Read the third time and passed.
6. March 20, 2025: Re-referred to INSURANCE & COMMERCE - SENATE
7. March 20, 2025: REPORTED CORRECTLY ENGROSSED
8. March 20, 2025: Amendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
9. March 20, 2025: Placed on second reading for purpose of amendment.
10. March 20, 2025: Rules suspended.

Votes

• Senate Roll Call #694 (March 31, 2025): 34 yea, 0 nay, passed
• Senate Roll Call #166 (February 11, 2025): 32 yea, 0 nay, passed

Common questions

What is SB331?

SB331 is a bill in the Arkansas Legislature (95th General Assembly (2025 Regular)): CONCERNING COVERAGE FOR GENETIC TESTING FOR INHERITED CANCER MUTATIONS; AND TO CREATE THE GENETIC TESTING ACT.

What does SB331 do?

In its own words: An act to be entitled an act concerning coverage for genetic testing for inherited cancer mutations; to create the genetic testing act; and for other purposes. subtitle concerning coverage for genetic testing for inherited cancer mutations; and to create the genetic testing act.

What is the status of SB331?

Failed as of May 5, 2025. Latest action: Died in House Committee at Sine Die adjournment. (May 5, 2025).

Who sponsored SB331?

Greg Leding (D, 30), with 1 co-sponsor.

Where is the official record for SB331?

On the Arkansas Legislature website: https://www.arkleg.state.ar.us/Bills/Detail?ddBienniumSession=2025%2F2025R&measureno=SB331